Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.8701
-0.0009 (-0.10%)
At close: May 12, 2025, 4:00 PM
0.8701
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Cytosorbents Employees
Cytosorbents had 149 employees as of December 31, 2024. The number of employees decreased by 37 or -19.89% compared to the previous year.
Employees
149
Change (1Y)
-37
Growth (1Y)
-19.89%
Revenue / Employee
$238,889
Profits / Employee
-$139,053
Market Cap
55.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTSO News
- 11 days ago - CytoSorbents Provides Regulatory Update for DrugSorb-ATR - PRNewsWire
- 13 days ago - CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 21 days ago - CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - PRNewsWire
- 25 days ago - CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PRNewsWire
- 4 weeks ago - CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America - PRNewsWire
- 5 weeks ago - CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - PRNewsWire
- 6 weeks ago - Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - PRNewsWire